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Hyaluronan is a linear glycosaminoglycan that has received special attention in the last few decades due to its extraordinary
physiological functions. This highly viscous polysaccharide is not only a lubricator, but also a signiﬁcant regulator of cellular
behaviors during embryogenesis, morphogenesis, migration, proliferation, and drug resistance in many cell types, including stem
cells. Most hyaluronan functions require binding to its cellular receptors CD44, LYVE-1, HARE, layilin, and RHAMM. After
binding, proteins are recruited and messages are sent to alter cellular activities. When low concentrations of hyaluronan are
applied to stem cells, the proliferative activity is enhanced. However, at high concentrations, stem cells acquire a dormant state
and induce a multidrug resistance phenotype. Due to the inﬂuence of hyaluronan on cells and tissue morphogenesis, with regards
to cardiogenesis, chondrogenesis, osteogenesis, and neurogenesis, it is now been utilized as a biomaterial for tissue regeneration.
This paper summarizes the most important and recent ﬁndings regarding the regulation of hyaluronan in cells.
1. HyaluronanProperties
Hyaluronan (also known as hyaluronate or hyaluronic acid,
HA) is a nonsulfated linear polysaccharide present in the ex-
tracellular matrix of every vertebrate’s tissue. It is a member
of the glycosaminoglycan (GAG) family and is synthesized at
the inner leaﬂet of the plasma membrane [1] as a large, un-
branched polymer of repeating disaccharides of glucuronic
acid and N-acetylglucosamine. It has a simple chemical
structure but diﬀers from other glycosaminoglycans in its
high molecular weight, lack of sulfate groups, and absence
of covalent attachment to core proteins [1]. It was assumed
that its major functions were in joint lubrication, tissue ho-
meostasis,andholding gel-like tissuestogether.However,the
high molecular weight of hyaluronan enables it to acquire a
viscous characteristic that goes beyond these functions. In-
deed, hyaluronan coregulates numerous physiological proc-
esses including embryonic development, inﬂammation, tis-
sue regeneration, cell migration, and proliferation. Some
reports [2, 3] have also suggested that hyaluronan plays some
roleincancerinvasionandinthepromotionofangiogenesis.
Many functions of hyaluronan depend upon its interac-
tion with cell surface receptors, including cluster determi-
nant 44 (CD44), receptor for hyaluronan-mediated motility
(RHAMM), lymphatic vessel endothelial hyaluronan recep-
tor (LYVE-1), hyaluronan receptor for endocytosis (HARE),
liver endothelial cell clearance receptor (LEC receptor), and
toll-likereceptor4(TLR4)[1].Althoughitiswellestablished
that hyaluronan-induced signaling occurs through receptor
interactions, its signal transduction mechanism in cells has
not been fully characterized.
Stem cells have the unique abilities of self-renewal and
pluripotency. These characteristics therefore play essential
roles in organogenesis during embryonic development and
tissue regeneration. The potential utility of stem cells for tis-
sue regeneration and treatment of many formerly incurable
diseases has motivated scientists to discover the key inﬂu-
ences of stem cell behavior. The identiﬁcation of hyaluronan2 Biochemistry Research International
in many locations where stem cells are present raised the
possibility that hyaluronan inﬂuences these potent cells. In-
deed, emerging studies [4–6] have proven the veracity of this
hypothesis, and hyaluronan is now being studied as a key
component that may be manipulated to induce desired stem
cell behaviors.
2.HyaluronanReceptors andSignaling
Hyaluronaninteractswithcellsurfacesinatleasttwoways.It
can bind cell surface receptors, hyaladherins, such as CD44,
LYVE-1, HARE, layilin, TLR4, and RHAMM, to induce the
transductionofarangeofintracellularsignals,eitherdirectly
or by activating other proteins. Through signal-transducing
receptors, hyaluronan inﬂuences cell proliferation, survival,
motility, and diﬀerentiation and might have roles in cancer
pathogenesis. The detail signaling mechanisms for each
receptor is reviewed as follows.
2.1. HARE. HARE, also known as stabilin-2, is a transmem-
brane receptor protein that contains a C-type lectin-like HA-
binding module, which enables binding and endocytosis of
hyaluronan ligand. The function of this receptor has been
regarded to be involved in the mediation of normal turnover
process of hyaluronan and other GAGs, such as chondroitin
sulfate, from the circulatory system. Hyaluronan is internal-
ized via a clathrin-coated pit pathway, leading to hyaluronan
degradation in the lysosome [7].
2.2. Layilin. Similar to HARE, layilin is a transmembrane
protein homologous to C-type lectins, which is located at the
membrane ruﬄe. It acts as a membrane docking site for talin
and can also speciﬁcally bind hyaluronan [8, 9] through its
lectin-like domain. Similar to CD44, layilin extracellularly
binds HA and induces binding of cytoskeletal proteins such
as talin and ERM complex through its cytoplasmic domain.
After receiving the HA signal, layilin interacts with merlin, a
protein of the ERM superfamily, at the amino terminus and
modulates cell cytoskeletal structure [10].
2.3. RHAMM. RHAMM is a ubiquitous protein which is
presentinthenucleus,cytoplasm,andcellplasmamembrane
[11–13]. RHAMM can be alternatively spliced to produce
molecules of diﬀerent sizes. When the membrane-bound
RHAMM interacts with hyaluronan, kinase activity of c-Src,
FAK, or PKC is activated [13, 14]; the intracellular RHAMM
domain is capable of binding kinase or cytoskeletal com-
ponents [11], forming a cytoskeleton regulating complex
and triggering cytoskeletal rearrangement. Disruption of hy-
aluronan-RHAMM interaction using either protein muta-
tion or antisense mRNA treatment signiﬁcantly reduces cell
motility rate and formation of stable focal adhesions [14],
supporting the model of RHAMM-mediated regulation of
FAK activity. It has been reported that RHAMM binding of
epiregulin, a novel ligand of EGFR, activates downstream ty-
rosine kinase-mediated autophosphorylation and regulates
cell survival and proliferation of human cementifying ﬁbro-
ma [15] cells (HCF).
2.4. LYVE-1. LYVE-1 is a type I integral membrane protein
containing a link domain, similar to the proteolytic hyaluro-
nan binding domain of the Link protein superfamily [16].
LYVE-1 is identiﬁed as an endocytic receptor of hyaluronan,
speciﬁcally expressed in the lymphatic endothelium. LYVE-1
has been widely used as a marker for investigation of lymph
vessel structure in both benign and malignant prostate tis-
sues and hence applicable in cancer-related studies. In HS-
578T human breast cancer cells, adhesion to COS-7 cells was
enhanced by overexpression of LYVE-1. This phenomenon
was reduced by enzyme digestion treatment of HS-578T cell
surface with bacterial Streptomyces hyaluronidase prior to
adhesion experiment, suggesting that LYVE-1 enhances tu-
mor cell adhesion through interaction with hyaluronan. A
recent study pointed out that in human primary eﬀusion ly-
mphoma (PEL) tumor cells, when LYVE-1 and EMMPRIN/
CD147 coexpressed with drug transporter protein, breast
cancer resistance protein/ABCG2 (BCRP), EMMPRIN in-
duced upregulation of BCRP, and LYVE-1 colocalized with
BCRP on the cell surface, suggesting that LYVE-1 takes part
in facilitating hyaluronan and EMMPRIN-mediated chemo-
resistance.
2.5. CD44. CD44-mediated cell interaction with hyaluronan
has been implicated in a variety of physiological events
including cell-cell and cell-substrate adhesion, cell migra-
tion, cell proliferation, and hyaluronan uptake and degra-
dation [17]. A proposed signaling pathway activated by the
CD44 receptor is depicted in Figure 1.H y a l u r o n a ni so f -
ten bound to CD44 isoforms, which are ubiquitous, abun-
dant, and functionally important cell surface receptors [18]
in coordinating intracellular signaling pathways (e.g., Ca2+
mobilization [19], Rho signaling [20], PI3-kinase/AKT
activation [21], NHE1-mediated cellular acidiﬁcation [22],
transcriptional upregulation, and cytoskeletal function [23])
and generating the concomitant onset of tumor cell activities
(e.g., tumor cell adhesion, growth, survival, migration, and
invasion) and tumor progression. CD44-hyaluronan inter-
action in MSC migration can be found in the rat MSC
line Ap8c3 and mouse CD44−/− or CD44+/+ bone marrow
stromal cells. Adhesion and migration of MSC Ap8c3 cells
[24] to hyaluronan was suppressed by anti-CD44 antibody
and by CD44 small interfering RNA (siRNA). In some tu-
mor studies, hyaluronan binding to tumor cells promoted
Nanog protein in association with CD44 followed by Nanog
activation and the expression of pluripotent stem cell regu-
lators such as Rex1 and Sox2. Nanog also formed a complex
with the signal transducer and activator of transcription pro-
tein 3 (Stat-3) in the nucleus leading to Stat-3-speciﬁc tran-
scriptionalactivationandMDR1(P-glycoprotein)multidrug
transporter gene expression [25].
Scientists have long noticed superﬁcial similarities be-
tween stem cells and cancer cells. We believe that CD-44
mediated cell interaction with hyaluronan will provide val-
uable new insights into previously understood aspects of sol-
id tumor malignancy. In fact, human breast cancer cells
strongly expressing CD44 along with low or no expression of
CD24 eﬀectively formed tumors. These cells possess theBiochemistry Research International 3
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Figure 1: Signaling through CD44: hyaluronan binding to a receptor such as CD44 or RHAMM will cause a conformational change in
t h er e c e p t o r .I nt h ec a s eo fC D 4 4 ,γ-secretase cleavage of the intracellular fragment can lead to phosphorylation of cellular components
such as CaMK (calmodulin kinase). Clustering of the intracellular portion of CD44 with cellular proteins such as merlin, Src, and PKC
leads to downstream activation of the Raf/MEK/ERK pathway, enhancing cell proliferation. Alternatively, activation with ankyrin, ERM,
or Vav2/Tiam1 leads to F-actin activation and cytoskeletal rearrangement, membrane ruﬄing, and cell motility. Hyaluronan signaling
also regulates cell migration and adhesion through interaction of PI3K and activation of the focal adhesion complex. PI3K activation by
hyaluronan signaling, when incorporated with the Akt pathway, may also lead to MDR and cell survival.
ability to diﬀerentiate, proliferate, and self-renew, com-
parable to normal stem/progenitor cells; hence, CD44+/
CD24low/− cells were considered to possess the stem/pro-
genitor cell phenotype [26]. Later, this idea was conﬁrmed
when epithelial mesenchymal transition (EMT) traits were
observed to correlate with the CD44+/CD24low/− stem cell
phenotype in human breast cancer [27]. Another marker,
ALDH1, further divides the CD44+CD24low/− cell popula-
tion into 2 fractions, in which the ALDH1+CD44+CD24low/−
cells are highly tumorigenic [28]. Forced expression of CD24
in CD44+CD24low/− cells resulted in decreased MEK/MAPK
signaling, reduced cell proliferation, and enhanced DNA da-
mage-induced apoptosis through attenuated NFκβ signaling
[29].Incontrast,siRNAsilencingofCD44-encodinggenesin
CD44+CD24low/− cells enhanced sensitivity to doxorubicin,
suggesting CD44 as a suitable target for treating cancer via
gene therapy [30].
This new understanding of hyaluronan/CD44-mediated
oncogenic signaling events may have important clinical util-
ity and could establish CD44 and its associated signaling
components (hyaluronan/CD44-mediated Nanog-Stat-3) as
important tumor markers for early detection and evaluation
of oncogenic potentials. This could also serve as groundwork
for the future development of new drug targets that may
inhibit hyaluronan/CD44-mediated tumor metastasis and
cancer progression.
3. HyaluronanConstitution in
theStemCellNiche
After the term “niche” was ﬁrst proposed in 1978 [31], im-
portant related studies in cell biology emerged, including
a focus on the mysterious microenvironment that supports
stemcells.Thestemcellnicheisnotsolelythelocationwhere
these cells are present but involves the surrounding cellular
components of the microenvironment and the signals ema-
nating from the support cells [32]. This niche requires an
environment that fosters a delicate balance between self-re-
newal and diﬀerentiation. Absence of this balance immedi
ately triggers inappropriate diﬀerentiation. Indeed, a de-
crease in proliferation potential of bone-marrow-derived
hematopoietic stem cells (HSC) has been observed in4 Biochemistry Research International
the absence of a “niche” environment [33]. Hematopoiesis,
the process by which HSC diﬀerentiate into hematopoietic
cells in order to generate diﬀerent blood cell types, is great-
ly inﬂuenced by the surrounding microenvironment. The
actual mechanism by which HSCs interact with the niche
environmentremainslargelyunknown;however,manystud-
ieshaveshownthattheHSCnicheisimportantforattracting
and anchoring HSCs. Hyaluronan, being a critical compo-
nent of the HSC microenvironment and widely distributed
in mesenchymal tissue, is thought to take part in the post-
natal hematopoietic niche since it is required for in vitro
hematopoiesis [34]. Hyaluronan degradation leads to an
arrest in HSC proliferation that is necessary for commitment
to the maturation of hematopoietic cells [34].
In vertebrates, hyaluronan appears to regulate cell trans-
formationandmigrationatseveralembryonicstages,asearly
as gastrulation. During embryogenesis, the accumulation
and organization of hyaluronan plays a role in the epithelial-
mesenchymal transition, a critical step in early embryogen-
esis for diﬀerentiation of pluripotent embryonic stem cells
(ESC) to mesenchymal stem cells (MSC) for further forma-
tion of diﬀerent tissues [35]. In general, endogenously pro-
duced hyaluronan contributes to diﬀerentiation of hESC to
mesodermal lineage, but more speciﬁcally to hematopoietic
cells [36]. The likely source of hyaluronan during early em-
bryonic developmental stages is hyaluronan synthase (Has) 2
[37]. Many cardiac or skeletal development anomalies are
due to inactivation or upregulation of hyaluronan synthe-
tases. It seems that interaction of hyaluronan with ESC is
fundamental to early embryonic development. Failure of
this interaction results in abnormal tissue formation. Hence,
hyaluronan has a central regulatory role during embryogen-
esis and morphogenesis [38, 39]. At later stages, Has1, Has2,
and Has3 are expressed in both undiﬀerentiated and diﬀer-
entiated hESC [36]. During embryonic development, hya-
luronan mostly interacts with cells via the RHAMM and
CD44receptors[15,34].High-molecular-weighthyaluronan
induces CD44 association with MEKK1 in epicardial cells to
promote epithelial mesenchymal transition and diﬀerentia-
tion [40]. However, more recent studies have observed that
the HA-CD44 signaling pathway is largely associated with
activation of ERK, by which the EGF receptor and down-
stream molecules such as Raf, MEK, and ERK1/2 are acti-
vated to promote cell proliferation [15]. ERK and its down-
stream molecules cyclin D1 and E2F also aﬀect cell cycle pro-
gression [41].
In addition to collagen, alginate, and ﬁbrin, hyaluronan
is one of the extracellular matrix molecules being used to
develop scaﬀolds forin vitro studies of stemcells,mainly due
to its great abundance in the stem cell niche environment.
Human ESCs may be maintained in an undiﬀerentiated state
by utilizing hyaluronan hydrogels [42], once more indicating
the importance of the interactions provided by hyaluronan.
4. Inﬂuence of Hyaluronan on
Stem Cell Behavior
MSCs are naturally sensitive to their environment, respond-
ing to chemical, physical, and mechanical features of their
matrices or substrates, as well as the spatial/temporal pre-
sentation of biochemical cues [43]. Hyaluronan inﬂuence in
behaviors such as adhesion, proliferation, diﬀerentiation,
and migration occurs through several newly discovered ge-
netic signaling mechanisms that involve binding to speciﬁc
cellular receptors.
4.1. Eﬀect of Hyaluronan on Mitochondrial Function. The ef-
fect of hyaluronan in cell behavior involves a direct inﬂuence
incellmetabolicactivityincludingbioenergetics.Fewstudies
have underscored this phenomenon in stem cells; however,
the ﬁrst report suggesting an inﬂuence of hyaluronan on mi-
tochondrial properties was obtained through studies of
chondrocytes from osteoarthritis (OA) patients, who exhibit
disrupted cellular behavior [44]. The fact that abundant lev-
els of hyaluronan are present in normal and healthy joint
areas and that these levels are dramatically diminished in OA
patients [44] suggests that hyaluronan abundance may be a
somewhat chondroprotective. Because oxidative stress, dis-
rupted mitochondrial respiration, and mitochondrial dam-
age promote aging, cell death, functional failure, and degen-
e r a t i o ni nav a r i e t yo ft i s s u e s[ 45], including joint regions,
it is possible that the putative chondroprotective role of hy-
aluronan may occur through the preservation of mitochon-
drial function. This was proven true when incubation of pri-
mary human chondrocytes from OA patients with hyaluro-
nan signiﬁcantly increased mtDNA integrity, improved ATP
levels, and increased cell viability under normal conditions
[44]. Moreover, hyaluronan ameliorated the negative eﬀects
of reactive oxygen and nitrogen species on mtDNA integrity,
mtDNA repair, ATP production, and cell viability, all of
which chondrocytes are exposed to during OA. Anti-CD44
antibody at saturating concentrations abolished the protec-
tive eﬀects of hyaluronan, which suggests the mechanism
is mediated by this receptor. CD44 promotes apoptotic resis-
tance in colonic epithelium via a mitochondria-controlled
pathway [46]. In addition, expression of CD44 in some cell
types, such as stem cells, may provide the means to inter-
nalize hyaluronan by endocytosis, and one of the functions
of internalized hyaluronan is to protect DNA from oxida-
tive metabolism [47]. In this study, high-molecular-weight
hyaluronan in culture medium prevented H2O2-induced
H2AX phosphorylation in 2 cell types. In contrast, the ef-
fect of low-molecular-weight hyaluronan was somewhat less
pronounced. Indeed, there is evidence that some glycosam-
inoglycans such as chondroitin-4-sulfate and hyaluronan in-
hibit lipid peroxidation caused by oxidative stress and there-
by decrease inﬂammatory reactions mediated by oxidants
[48]. These conditions mimic the situation in vivo when cells
are growing within an intercellular matrix containing hyalu-
ronan and are exposed to an exogenous oxidizing agent.
This supports the proposition that one of the biological
functions of hyaluronan is to provide protection against cel-
lular damage caused by radicals produced by oxidation or
ionizing radiation.
Stem cells thus may have several diverse mechanisms to
protect the integrity of their DNA, such as by maintaining
low metabolic activity to ensure minimal oxidative damage,
having a highly eﬀective eﬄux pump that rapidly removesBiochemistry Research International 5
genotoxic agents from the cell [49], and possibly allowing
internalization of hyaluronan, which protects DNA from
oxidants. These mechanisms may be coordinated with each
other and with cell cycle status. However, information is
sparse concerning how exactly CD44 may aﬀect mitochon-
drial function. Stem cell mitochondria have recently come
under increased scrutiny because new information has re-
vealed their role in numerous cellular processes, beyond ATP
production and apoptosis regulation, suggesting mitochon-
dria to serve as a cell fate or lineage determinant [50–52].
Thus, hyaluronan inﬂuence on mitochondrial properties
may at least to some extent aﬀect stem cell self-renewal and
diﬀerentiation. Unfortunately, no ongoing studies have been
published thus far.
4.2. Cell Migration. Observations made by a very successful
research group in Boston in the beginning of the 1970s
revealed that hyaluronan accumulation coincides with peri-
ods of cellular migration [53]. This event may occur through
the physiochemical properties of hyaluronan or via direct
interaction with cells. When hyaluronan is synthesized and
released to the extracellular environment, its physiochemical
characteristics of viscosity and elasticity contribute to local
tissue hydration. This results in weakening of cell anchorage
to the extracellular matrix, allowing temporal detachment
to facilitate cell migration and division [54]. Chemically,
this can be explained by the hyaluronan structure. In dilute
solutions, where the domain that is occupied by each
hyaluronan molecule expands because of mutual repulsion
between the carboxyl groups inside its structure, a large
volumewilleventuallybeoccupiedwithwatertrappedinside
it. This property provides resilience and malleability to many
tissues so that in hyaluronan-rich areas internal pressure
may cause the separation of physical structures and create
“highways” for cell migration; during fetal development, the
migration path through which neural crest cells migrate is
rich in hyaluronan [55]. Another example is the migration
of mesenchymal cells into the cornea following increased
hyaluronan deposition, hydration, and concomitant swelling
of the migratory pathway [56]. Beyond the physiochem-
ical interactions with hyaluronan, cells may be able to
mediate, direct, and control their migration and locomotor
mechanism through speciﬁc interactions via cell surface
hyaluronan receptors. The principal cell surface receptors
include CD44, RHAMM, and ICAM-1 [17]. RHAMM in
particular forms links with several protein kinases associated
with cell locomotion, for example, extracellular signal-
regulated protein kinase (ERK), p125fak,a n dp p 6 0 c−src [17].
Increased cell movement in response to hyaluronan can also
be demonstrated experimentally in other cell types, and cell
movement can be inhibited, at least partially, by degradation
and/or blocking of hyaluronan receptor occupancy.
4.3. Cell Cycle and Proliferation. The formation and repair
of mature hard tissue require cell proliferation. Hyaluronan
levels have been shown to have a direct inﬂuence on this
event. Cell proliferation is activated by hyaluronan, which
increases volume and surface area for cell migration and
cellular activities, and stimulates receptor-mediated events.
Hyaluronan can form a pericellular coat, settle into a cell-
poor space, and facilitate cell detachment from the matrix
and mitosis in response to mitogenic stimulators such as
preinﬂammatorymediators andgrowthfactors[57].Human
ﬁbroblasts synchronized with colchicine or cytochalasin
showed increased hyaluronate synthesis at the time of cell
rounding during mitosis but declined sharply as cells entered
G1-phase and resumed the spread morphology [57]. It is
reasonable to suggest that basal levels of hyaluronan syn-
thesis during the G1,S ,a n dG 2 phases could be used for
cell migration; during mitosis, synthase activity could be
activatedatallcellularcontactareastocausedetachmentand
rounding.Thehighlocalconcentrationofhyaluronancauses
release of endogenous growth factors and stimulates cell-
cell interaction, resulting in faster cell proliferation during
early stages of in vitro culture [58]. Although hyaluronan
facilitates cell detachment, it has not been shown to possess
direct mitogenic activity. However, by facilitating cell mitosis
in response to mitogenic factors that are abundant during
the early phases of tissue repair, hyaluronan may also have an
important, although indirect role in cell proliferation [17].
M a n yr e p o r t sh a v ee x p e r i m e n t a l l yc o n ﬁ r m e dt h i si d e a ,
demonstrating the acceleration of stem cell proliferation
by hyaluronan. In previous studies using mouse adipose-
derived stem cells (mADSCs), we showed that supplementa-
tion of the culture medium with minute amounts of high-
molecular-weight hyaluronan increases the growth rate of
mADSCs at early passages, contributes to the extension of
their lifespan with a marked reduction of cellular senescence
during subcultivation, and prolongs their diﬀerentiation
potential [4]. When mADSCs were cultured on a hyaluronan
precoated surface, cell aggregates formed with a much
more gradual growth proﬁle. Hyaluronan-containing matrix
seemed to be a poor attachment substratum for cell growth,
as previously observed [59]. At later passages, aggregation
limited propagation and contact inhibition, resulting in a
slight increase of p16INK4a expression, consistent with pre-
vious reports [60]. Our study provided evidence that pla-
centa-derived mesenchymal stem cells (PDMSCs) grown
on a hyaluronan-coated surface are maintained in slow-cy-
cling mode and that a prolonged G1 phase occurs through
elevated levels of p27kip and p130, which are responsible
for suppressing cell entry into S-phase [6]. This in turn
may be the main cause of reduced proliferation observed in
stem cells cultured on hyaluronan-coated surfaces [4]. This
line of evidence was conﬁrmed by another research group
who found that a high percentage of primary rat calvarial
osteoblasts, in the presence of sulfated hyaluronan (HAS)
derivatives, remained in G1 phase with a concomitant de-
crease in the number of cells in S and G2/M phase, even-
tually leading to a decrease in cell proliferation [61]. Rec-
ent studies have shown that prolonged G1 transit is as-
sociated with an increase in p27Kip1 [62]. Because p27
phosphorylation by cyclin E/Cdk2 is a prerequisite for its
ubiquitination and degradation, it is interesting that in
CD44-treatedcellscyclinE/Cdk2kinaseactivityisdecreased,
suggesting that CD44 might inhibit the ubiquitin-dependent
proteolytic pathway of p27, leaving this molecule in an active
form [62]. The speciﬁc signaling cascade that inhibits p276 Biochemistry Research International
degradation via CD44 remains to be characterized. However,
it was speculated that blockage of the Ras pathway, which
represents a principal force in driving the cell cycle [63], is
involved in this process [64–66].
Hyaluronan thus appears to be eﬀective in maintaining
mADSCsinaproliferativestate,delayssenescence,and,more
strikingly, directly inﬂuences cell proliferation. Diﬀerent
forms of hyaluronan supplementation may cause distinct
proliferative behaviors in stem cells. Although the mecha-
nism by which hyaluronan promotes or slows proliferation
andpreservesthediﬀerentiationpotentialofmADSCsmerits
further investigation, the addition of hyaluronan to a culture
system may be a useful approach for expanding adult stem
cells in vitro without losing their replicative and diﬀerentia-
tion capabilities.
4.4. Cell Diﬀerentiation. In native tissue, MSCs reside in a
deﬁned microenvironment that regulates stem cell survival,
self-renewal,anddiﬀerentiationthroughgrowthfactors,cell-
cell contact, and cell-matrix adhesion. This occurs due to
the direct inﬂuence of cell adhesion to their underlying bio-
materials. Although soluble factors are potent regulators of
stem cell diﬀerentiation, recent discoveries have underscored
the importance of the physical and chemical characteristics
of the matrices in determining stem cell fate [67]. Long-
term culture of undiﬀerentiated ESCs on a hyaluronan-
coated surface instead of feeder layers yields pluripotency
and diﬀerentiation characteristics similar to those of cells
cultured on mouse embryonic ﬁbroblasts (mEF) after 1
month of culture [68]. It seems that hyaluronan matrices act
as a unique microenvironment for propagation of hESCs,
likely due to the regulatory role of hyaluronan in the
maintenance of hESCs in their undiﬀerentiated state in vitro
and in vivo. Indeed, in humans, the hyaluronan content is
greatest in undiﬀerentiated cells during early embryogenesis
and decreases at the onset of diﬀerentiation [39]. It has
b e e ns u g g e s t e dt h a th E S C sa r ea b l et ot a k eu pa n dd e g r a d e
hyaluronan through CD44 and thereby remodel hyaluronan
matrices, a feature necessary for cell survival and migration
[42]. After activation of several environmental cues that
dictate the need for fully diﬀerentiated cells, hyaluronan
supplementation may in turn induce faster cell attachment
and enhance cell diﬀerentiation, possibly through improved
cell-cell communication [33]. How hyaluronan may mediate
this event is still unknown but has been conﬁrmed by a
new, engineered class of hyaluronan-based hydrogels that
provide a natural extracellular matrix environment with a
complex mechanical and biochemical interplay. The hydro-
gel induced osteoblast diﬀerentiation of MSCs without the
use of osteogenic media. This most likely occurred through
the enhancement of cell adhesion [33].
4.5. Multidrug Resistance. “Classic multidrug” resistance
(MDR) is caused by increased drug export through ATP-de-
pendent eﬄux pumps, such as multidrug-resistance proteins
(MRPs), and other members of the ATP-binding cassette
(ABC)transporterfamilies[69].Theﬁndingthathyaluronan
stimulatescellsurvivalsignalingandthattreatmentoftumor
cells with hyaluronidase increased the activities of various
chemotherapeutic agents [70] led to the further inves-
tigation of the possible role of hyaluronan in drug resistance.
Increased hyaluronan production stimulates drug resist-
ance in drug-sensitive cancer cells, whereas disruption of
endogenous hyaluronan-induced signaling suppressed resis-
tance to doxorubicin, taxol, vincristine, and methotrexate
[71]. Therefore, the eﬀects of hyaluronan on cell-sur-
vival signaling might alter drug resistance. Although the
antiapoptotic eﬀect of hyaluronan probably contributes to
these phenomena, it is also known that lipid products
of PI3K, such as phosphatidylinositol-3,4-diphosphate,
and phosphatidylinositol-3,4,5-triphosphate, directly medi-
ate the function of ABC transporters that are involved in
bile transport [72]. Because hyaluronan stimulates PI3K
activity, it might also inﬂuence drug resistance by stim-
ulating drug transport [2]. Thus, transmembrane pumps
may induce MDR by decreasing the intracellular accumu-
lation and retention of drugs. Of particular interest is a
recent work [73] indicating that inhibitors of MDR block
hyaluronan synthesis and secretion and that hyaluronan
might be secreted through multidrug transporters. Another
possible regulator of hyaluronan-mediated multidrug resis-
tance is the extracellular-matrix metalloproteinase inducer
(EMMPRIN). EMMPRIN also stimulates the production
of hyaluronan in mammary carcinoma cells [74]. Conse-
quently, EMMPRIN promotes cell-survival signaling and in-
duces multidrug resistance in a hyaluronan-dependent man-
ner. In previous studies, we provided evidence that PDMSCs
grown on a concentrated hyaluronan-coated surface become
doxorubicin-resistantandthattheinteractionbetweenCD44
and hyaluronan is crucial for this drug resistance [5]. Hy-
aluronan-CD44 interactions upregulate expression of drug
transporters, including MDR1 [75], MRP2 [75], and BCRP
[76]. In addition, small fragments of hyaluronan may medi-
ate multidrug resistance by binding to CD44 and promoting
translocation of a speciﬁc transcriptional regulator (YB-1)
of the multidrug resistance MDR1 gene. This event simul-
taneously induces P-glycoprotein, the product of the MDR1
gene,andabroad-spectrummultidrug eﬄux protein present
in both cancerous and healthy cells. Previous studies have
reported that MDR is an important regulator of stem cell
commitment [77]. Thus, we suggest that P-glycoprotein in-
duced by the hyaluronan-coated surface holds PDMSCs in
a primitive state by enabling them to extrude molecules re-
quired for diﬀerentiation. To the best of our knowledge,
no reports have been published on MDR acquisition in
mesenchymal stem cells; therefore, our study was the ﬁrst to
show that a hyaluronan substratum induces PDMSCs to
acquire MDR as a result of increased P-glycoprotein ex-
pression through CD44 signaling. These and previous obser-
vations [4, 6] lead us to suggest that hyaluronan may cause
PDMSCs to become dormant, the natural state of stem cells,
which is consistent with slow cycling and drug resistance [5].
5. HyaluronanRegulates TissueMorphogenesis
Hyaluronan plays an important role in many morphogenet-
ic processes during vertebrate development. InteractionBiochemistry Research International 7
of hyaluronan with surrounding stem cells regulates cell
diﬀerentiation or the fate of cells. After hyaluronan comes in
contact with surrounding cells through receptors, hyaluro-
nandegradationbyproteolysisreleasescell-associatedfactors
which aﬀect cell motility.
5.1. HA in Cardiogenesis. High-molecular-weight hyaluro-
nan (HMW-HA) stimulated epicardial cells, during forma-
tion of coronary vasculature in embryonic development,
promoted association of hyaluronan receptor CD44 with
MEKK1 protein, induced MEKK1 phosphorylation, and ac-
tivated the ERK-dependent and NFκB-dependent pathways.
Two methods of CD44 blockage decreased the HMW-HA-
induced invasive response in epicardial cells [40]. Recent de-
velopmentofhyaluronanmixedestersofbutyricandretinoic
acids to improve the yield of cardiovascular stem cells
revealed an enhancement in smad1, 3, and 4 gene expression
and further upregulation of the cardiogenic gene Nkx-2.5
expression, which led to high cardiogenesis from stem cells
[78].
5.2. HA in Osteogenesis and Chondrogenesis. The application
of hyaluronan for bone regeneration is well known. In fact,
the importance of hyaluronan in spine development was
found in a hyaluronan synthase-2 (Has2) knockout mouse
model [79]. Previous reports and our unpublished data have
demonstrated the potential of hyaluronan in the enhanced
chondrogenic and osteogenic diﬀerentiation potentials of
mesenchymal stem cells via stimulated expression of speciﬁc
target genes. These genes include chondrogenic markers
such as sulfated glycosaminoglycans, SOX-9, aggrecan, and
collagen type II; osteogenic markers alkaline phosphatase
(AKP), osterix, runx2, and collagen type I [80–82].
5.3. HA in Neurogenesis. There is substantial evidence of
hyaluronan participation in morphogenesis and neural cell
diﬀerentiation in the central nervous system. Sulfated hy-
aluronan can increase proliferation of normal human astro-
cytes and diﬀerentiation through enhanced expression of
connexin-26, -32, and -43 [83]. Hyaluronan-containing hy-
drogels provide a suitable environment for neural stem cell
growth and diﬀerentiation [84, 85].
5.4. HA in Angiogenesis. Previous reports have shown that
tumor growth and metastasis are dependent on neovascular-
ization, and oligo-hyaluronan induces angiogenesis in vivo
[3]. Oligo hyaluronan-induced proliferation of endothelial
cells and tube formation during angiogenesis is mediated by
CD44 signaling, followed by phosphorylation of Src, FAK,
and ERK1/2 proteins, leading to upregulation of c-jun and
c-fos. This phenomenon is reversed after silencing of CD44
with siRNA [86]. Hyaluronan has been tested for cell ther-
apy in a limb ischemic mouse model and was shown to en-
hance angiogenesis and improve revascularization [55]. Our
unpublished data demonstrated that in vitro culture of
PDMSCs with high-molecular-weight hyaluronan slightly
increased the expression of angiogenic markers, including
KDR, CD31, and vWF.
6. Role of HyaluronanandStem Cellson
Tissue Regeneration
Hyaluronan plays an important role in preservation of the
normalextracellularmatrixstructureandinducesneodermis
at the wound bed [87]. It is extensively used as an important
component of assorted categories of biomaterials. Hyaluro-
nan, which supports stem cell interaction with extracellular
matrixmolecules[88],iscapableofregulatingtheinﬂamma-
tory chemokines, receptors, metalloproteinases, and tissue
inhibitors that are necessary to form an eﬃcient scaﬀold.
Modulation of the expression of inﬂammatory factors
(CXCL12, CXCL13, and CXCR5) in mesenchymal stem cells
by hyaluronan contributes to regenerative processes [89]. In
addition, fragmented hyaluronan stimulates inﬂammatory
gene expression in various immune cells at injury sites via
TLR4, TLR2, and CD44 [90]. This occurs through downreg-
ulation of the anti-inﬂammatory A2a receptor [91]. During
leukocyte recruitment, hyaluronan interaction with CD44
activates various inﬂammatory cells, such as macrophages,
through CD44-dependent signaling [92]. In contrast, low-
molecular-weight hyaluronan induces dendritic cell matura-
tion and promotes dendritic and endothelial cell release of
proinﬂammatory cytokines such as TNFα,I L - 1 β, and IL-12
through TLR4 [93, 94]
The migratory, proliferative, and diﬀerentiation inﬂu-
ences of hyaluronan in stem cells provide insights for the de-
velopment of potent biomaterials for regeneration of full-
thicknesswounds(e.g.,diabeticfootulcerandburnwounds)
through initial restoration of the dermal layer and a later
application of diﬀerentiated local cells that may lead to faster
and better regeneration [95]. For instance, regeneration of
bone defects can be achieved by combining cells and oste-
ogenic signals in a suitable scaﬀold. Combination of human
bone-marrow-derived mesenchymal stromal cells and TGFβ
growthfactorinvolvedinchondrogenesis,onacommercially
available hyaluronan biomaterial scaﬀold showed that cells
were capable of proliferating and diﬀerentiating, forming a
cartilage-like construct in vitro with increased expression of
typical chondrogenic markers [88]. Combination of stem
cells with bone morphogenetic protein-2 (BMP-2) in hyalu-
ronan-based hydrogel has also been widely used for the same
purpose [96].
Neuralstemcell(NSC)therapycanbeusedfornerveand
brain regeneration. Hyaluronan is the major extracellular
matrix component of the adult central nervous system. Its
presence alone is necessary for the diﬀerentiation of NSCs to
neuronal cells in vitro [84]. Nevertheless, other reports have
shown that using a 3D scaﬀold composed of HA, collagen,
andthenervegrowthfactorneurotrophin-3 providedperfect
nerve regeneration in vivo through diﬀerentiation of NSCs
[97]. The eﬃcacy of hyaluronan in several aspects of tissue
regeneration is becoming better understood. This knowledge
provides important insights into the therapeutic utility of
stem cells in human disease.
7. Conclusion
The physiological role of hyaluronan, especially in regulation
of cellular activities, may provide a potent therapeutic8 Biochemistry Research International
alternative with profound advantages. However, this hypoth-
esis cannot be applied to clinical practice without a more
complete biological understanding of its mechanisms. Dif-
ferent mechanisms of hyaluronan regulation in stem cells are
now emerging but at a very slow pace. The possibility of
maintaining stemness or even inducing diﬀerentiation
by manipulation of hyaluronan concentration/molecular
weight, or by targeting genes activated by hyaluronan, may
be a start point in the race to ﬁnd new therapies for fatal
diseases. Still, many knowledge gaps need to be ﬁlled, open-
ing a window for future research eﬀorts.
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